BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 28664413)

  • 1. Molecular profiling of sarcomas: new vistas for precision medicine.
    Al-Zaid T; Wang WL; Somaiah N; Lazar AJ
    Virchows Arch; 2017 Aug; 471(2):243-255. PubMed ID: 28664413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of genetic and molecular profiling in sarcomas.
    Norberg SM; Movva S
    Curr Treat Options Oncol; 2015 May; 16(5):24. PubMed ID: 25939540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classification of sarcomas using bioinformatics and molecular profiling.
    Dang TA; Man TK
    Curr Pharm Biotechnol; 2007 Apr; 8(2):83-91. PubMed ID: 17430156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Next-Generation Sequencing in Sarcomas: Evolution From Light Microscope to Molecular Microscope.
    Groisberg R; Roszik J; Conley A; Patel SR; Subbiah V
    Curr Oncol Rep; 2017 Oct; 19(12):78. PubMed ID: 29030741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.
    Groisberg R; Hong DS; Holla V; Janku F; Piha-Paul S; Ravi V; Benjamin R; Kumar Patel S; Somaiah N; Conley A; Ali SM; Schrock AB; Ross JS; Stephens PJ; Miller VA; Sen S; Herzog C; Meric-Bernstam F; Subbiah V
    Oncotarget; 2017 Jun; 8(24):39254-39267. PubMed ID: 28424409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Strategies in Sarcoma: Linking Genomic and Immunotherapy Approaches to Molecular Subtype.
    Lim J; Poulin NM; Nielsen TO
    Clin Cancer Res; 2015 Nov; 21(21):4753-9. PubMed ID: 26330427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing the genomic revolution in cancer diagnostics.
    Nguyen D; Gocke CD
    Virchows Arch; 2017 Aug; 471(2):175-194. PubMed ID: 28639053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colorectal cancer molecular profiling: from IHC to NGS in search of optimal algorithm.
    Furtado LV; Samowitz WS
    Virchows Arch; 2017 Aug; 471(2):235-242. PubMed ID: 28551725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next-generation sequencing for the management of sarcomas with no known driver mutations.
    Vyse S; Thway K; Huang PH; Jones RL
    Curr Opin Oncol; 2021 Jul; 33(4):315-322. PubMed ID: 33927108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Machine learning analysis of gene expression data reveals novel diagnostic and prognostic biomarkers and identifies therapeutic targets for soft tissue sarcomas.
    van IJzendoorn DGP; Szuhai K; Briaire-de Bruijn IH; Kostine M; Kuijjer ML; Bovée JVMG
    PLoS Comput Biol; 2019 Feb; 15(2):e1006826. PubMed ID: 30785874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of gene expression arrays in sarcomas.
    Skubitz KM; Skubitz AP
    Curr Oncol Rep; 2004 Jul; 6(4):309-14. PubMed ID: 15161587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling for the investigation of soft tissue sarcoma pathogenesis and the identification of diagnostic, prognostic, and predictive biomarkers.
    Beck AH; West RB; van de Rijn M
    Virchows Arch; 2010 Feb; 456(2):141-51. PubMed ID: 19412622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling in sarcomas.
    Tschoep K; Kohlmann A; Schlemmer M; Haferlach T; Issels RD
    Crit Rev Oncol Hematol; 2007 Aug; 63(2):111-24. PubMed ID: 17555981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular Pathogenesis and Diagnostic, Prognostic and Predictive Molecular Markers in Sarcoma.
    Mariño-Enríquez A; Bovée JV
    Surg Pathol Clin; 2016 Sep; 9(3):457-73. PubMed ID: 27523972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular pathological analysis of sarcomas using paraffin-embedded tissue: current limitations and future possibilities.
    van de Rijn M; Guo X; Sweeney RT; Beck AH; West RB
    Histopathology; 2014 Jan; 64(1):163-70. PubMed ID: 24107169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Next-Generation Sequencing for Patients with Sarcoma: A Single Center Experience.
    Cote GM; He J; Choy E
    Oncologist; 2018 Feb; 23(2):234-242. PubMed ID: 28860410
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The molecular pathology of sarcomas.
    Powers M; Zhang W; Lopez-Terrada D; Czerniak BA; Lazar AJ
    Cancer Biomark; 2010; 9(1-6):475-91. PubMed ID: 22112491
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microarray analysis of sarcomas.
    Nielsen TO
    Adv Anat Pathol; 2006 Jul; 13(4):166-73. PubMed ID: 16858150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Cancer: three eras of personalized medicine].
    Jordan B
    Med Sci (Paris); 2017 Oct; 33(10):905-908. PubMed ID: 28994388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Profiling of potential driver mutations in sarcomas by targeted next generation sequencing.
    Andersson C; Fagman H; Hansson M; Enlund F
    Cancer Genet; 2016 Apr; 209(4):154-60. PubMed ID: 26987750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.